The COVID-19 pandemic highlighted critical supply chain challenges as health agencies like the Food and Drug Administration faced new, unforeseen demands. Dr. Heather Agler joins us from HIMSS 2022 to discuss how FDA investigated data and developed new methods to better inform stockpiling strategies for critical supplies like ventilators, personal protective equipment (PPE) and more, as well as share her thoughts on what comes next in health IT.
HealthCast
28m listen
Live from HIMSS: FDA is Improving Supply Chain Resiliency to Combat Future Challenges
Share
FDA’s Heather Agler from CDRH talks leveraging lessons learned from COVID-19 to improve supply chain resiliency and develop new solutions.
-
Heather Agler Senior Program Manager CDRH, FDA
Related Content
-
OMB Seeks Public Comment on Landmark Federal Acquisition Overhaul
The first proposed FAR revisions would streamline procurement, modernize acquisition and establish regular reviews to curb regulatory growth.
3m read -
Misunderstood ATOs Are Costing Agencies Time, Money
Institutional confusion about ATOs is creating avoidable delays, while modern DevSecOps approaches offer a faster path to software delivery.
9m watch -
DOE Launches $17.5 Billion Nuclear Effort Amid AI Power Demand
A financing program seeks to accelerate nuclear projects as electricity demand grows from data centers, manufacturing and national security.
3m read -
CISA is Evolving How it Defines Critical Infrastructure
CISA plans to roll out new collaboration frameworks in the coming weeks to strengthen critical infrastructure cybersecurity.
3m read
